Synopsys Inc. filings document the regulatory record for a Nasdaq-listed engineering software company whose common stock trades under SNPS. The company’s disclosures cover operating and financial results, capital allocation actions such as stock repurchase authorizations and accelerated share repurchase agreements, and material-event reports tied to governance, executive roles, and organizational changes.
Proxy and annual meeting materials describe board elections, shareholder voting matters, executive compensation, equity incentive plan approvals, and corporate governance practices. Recent Form 8-K filings also document restructuring actions following the completed Ansys acquisition, amendments to prior governance disclosures, registered common stock details, exhibits, and risk-oriented statements associated with forward-looking business actions.
Synopsys (SNPS) President and CEO Ghazi Sassine exercised non-qualified stock options for 14,604 shares on October 15, 2026, at an exercise price of $135.8800 per share, acquiring 14,604 common shares. He sold 14,604 common shares that day at a weighted average price of $462.8430 per share; the sale transactions ranged from $455.060 to $471.325 per share. The transactions were effected under a Rule 10b5-1 trading plan adopted September 19, 2025.
Synopsys, Inc. is the issuer named in a notice that Sassine E. Ghazi proposes to sell 14,604 common shares on October 15, 2026, with an aggregate market value of $6,759,359.17. The securities details identify the shares as acquired from the issuer through a stock option exercise. Ghazi also reported selling 14,604 common shares on September 15, 2026, with an aggregate market value of $5,474,683.26.
Synopsys Inc. (SNPS) GC & Corporate Secretary Janet Lee reported two direct sales of common stock on October 6, 2026: 584 shares at a weighted average price of $502.6399 per share and 560 shares at $502.3950 per share. The first sale’s weighted average covered multiple transactions. No Rule 10b5-1 plan is reported for the sales.
Synopsys Deputy CFO & CAO Sudhindra Kankanwadi exercised non-qualified stock options for 9,170 common shares at $135.88 per share on October 6, 2026, then sold 9,170 shares at $500 per share. On October 5, 2026, he exercised options for 3,000 common shares at $135.88 per share and sold 3,000 shares at $484.78 per share. No Rule 10b5-1 plan is reported.
Janet Lee, an officer of Synopsys, Inc. (SNPS), reported a proposed sale of 1,144 common shares, with an aggregate market value of $574,882.90. Morgan Stanley Smith Barney LLC is listed as broker, and October 6, 2026 is the approximate sale date. The shares are represented by three entries: 395 and 165 shares of restricted stock and 584 shares as merger consideration.
Synopsys, Inc. (SNPS) officer Sudhindra Kankanwadi reported a proposed sale of 9,170 common shares with an aggregate market value of $4,585,000, dated October 6, 2026, through Morgan Stanley Smith Barney LLC on Nasdaq. The notice lists a 9,170-share stock option exercise from the issuer for cash on October 6, 2026. It also reports a sale of 3,000 common shares on October 5, 2026, for $1,454,340.
Synopsys, Inc. officer Sudhindra Kankanwadi reported a proposed sale of 3,000 common shares, with an aggregate market value of $1,454,340.00 and an approximate sale date of October 5, 2026. Morgan Stanley Smith Barney LLC is listed as broker. The securities information lists the 3,000 shares as acquired from the issuer through a stock option exercise on October 5, 2026, with cash payment.
Synopsys, Inc. entered into an accelerated share repurchase agreement with JPMorgan Chase Bank, National Association to repurchase an aggregate of $1 billion of Synopsys common stock.
Synopsys will receive an initial delivery of approximately 1,735,000 shares. Any remaining shares are to be settled on or before January 5, 2027, upon completion of the repurchases. The final number of shares is based on the average of Synopsys’ daily volume-weighted average share prices during the repurchase period, less a discount.
The release describes settlement as expected and identifies share prices during the repurchase period and JPMorgan Chase Bank, National Association’s ability to buy or borrow shares among factors that could cause actual results or timeframes to differ materially. It also cites global and regional economic and market conditions, including illiquidity and instability in banking and financial services.
SYNOPSYS INC (SNPS) reported that President and CEO Ghazi Sassine exercised stock options and sold the resulting shares on September 15, 2026. He exercised options for 14,604 shares of common stock at an exercise price of $135.88 per share, then sold 14,604 shares of common stock at a weighted average price of $374.8756 per share in multiple transactions. The options were originally exercisable from December 12, 2020 and are scheduled to expire on December 12, 2026, and after this transaction 14,604 options from this grant remained outstanding. All transactions were effected under a Rule 10b5-1 trading plan adopted on September 19, 2025.
SYNOPSYS, INC. (SNPS) is the issuer in a notice that Sassine E. Ghazi plans to sell shares of its common stock under Rule 144. The notice reports an intent to sell 14,604 shares, with an aggregate market value of $5,474,683.26, when shares outstanding were 191,636,646 as of September 15, 2026.
The shares are to be sold through Morgan Stanley Smith Barney LLC and are tied to a stock option exercise for cash dated September 15, 2026.